The defect of ERK activation in AML-exposed CAR T cells may be related to the decreased expression of previously reported upstream activators of ERK, such as PDGFA15, NTRK116, MTURN17, IGF118, and CFLAR19, and increased DUSP120, a phosphatase that inactivates ERK. Here, EPHB2 is linked to acute myeloid leukemia.